All Resources
Explore our latest resources
Viz.ai Announces New Clinical Data Demonstrating Fewer Futile Transfers and Substantial Cost Savings...
Company’s artificial intelligence technology shows 14% increase in patient transfers treated with endovascular thrombectomy supporting its impact on improved care...
Sep 26, 2024
Sep 25, 2024
Sep 25, 2024
September 17, 2024
TIME Selects Viz.ai CEO Dr. Chris Mansi in TIME100 AI List of the...
SAN FRANCISCO – September 5, 2024 - Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, is pleased...
Sep 05, 2024
Sep 05, 2024
Viz.ai and ALCMI Partner to Unite AI and Lung Cancer Research Communities
New partnership brings together AI experts and lung cancer researchers to improve early disease detection SAN FRANCISCO – September 4,...
Sep 04, 2024